Tag: Myeloid Therapeutics MT-303 research

news-10112024-031443

MT-303: First In Vivo GPC3 Targeting mRNA CAR for HCC – SITC 2024 Oral...

Myeloid Therapeutics, Inc. announced an oral presentation at the Society for Immunotherapy in Cancer (SITC) 2024 annual meeting in Houston, Texas. Dr. Matthew Maurer,...

BREAKING NEWS

Random News

Most Read News